Equibles does not estimate personal net worth.
Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLSI alertsMary Szela is recorded as CEO and Board Member at TriSalus Life Sciences, Inc. (TLSI). The newest filing on record that lists Mary Szela as CEO and Board Member at TriSalus Life Sciences, Inc. (TLSI) is dated March 31, 2026. TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Mary Szela was appointed director, effective August 10, 2023. TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Mary Szela was appointed Chief Executive Officer and President, effective August 10, 2023. The proxy statement of TriSalus Life Sciences, Inc. reports total compensation of $4,823,349 for Mary Szela in fiscal 2025, including a base salary of $600,920. Disclosed compensation is on record for 4 fiscal years. Mary Szela has spoken on 11 earnings calls and 2 other investor events across 1 company, most recently for TriSalus Life Sciences, Inc. on September 14, 2026. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member), David B. Patience (CFO) and 7 others.
“Upon the Closing, each of Mary Szela, Sean Murphy, Mats Wahlström, Andrew von Eschenbach, George Kelly Martin, David J. Matlin, Arjun Desai, Kerry Hicks and Anil Singhal were elected to serve as directors on the New TriSalus Board.”
“Immediately following Closing, the New TriSalus Board appointed the following individuals as the Company's executive officers: Mary Szela to serve as Chief Executive Officer and President, Sean Murphy to serve as Chief Financial Officer, James Alecxih to serve as President, Device Technology, Steven Katz to serve as Chief Medical Officer, Bryan Cox to serve as Chief Scientific and Manufacturing Officer, Jennifer Stevens to serve as Chief Regulatory Officer, and Richard Marshak to serve as Senior Vice President, Corporate Development & Strategy.”
“One of the things that we as a company feel very proud of is that we want to be an evidence-driven company. So we want to produce, you know, comparative clinical trials to really demonstrate the value of the product.”
“Well, first of all, thank you so much to the Canaccord team. I'm delighted to be here. I think I'm going to move around. That light is right in my face. Well, good morning, everyone.”
“I'm pleased to report a strong second quarter with total revenue of over $11.4 million. This reflects sequential and year-over-year growth as we continue to raise awareness of TriNav while building clinical evidence and strengthening our commercial foundation.”
“Second, the deliberate realignment and significant expansion of our commercial organization, creating a foundation to capture the multi-year growth that a cadence of new clinical and health economic evidence will unlock over the next 18 months.”
“Thank you for joining us for a review of our 2025 fourth quarter and year-end financial results. I'll begin with a high-level review of our results for the quarter and the year, recap some of the highlights from recent weeks, and then provide an overview of our longer-term strategy and expectations for 2026 and beyond.”
2023-08-10–present
Start not stated–present
Last confirmed March 31, 2026
Start not stated–present
Last confirmed March 31, 2026
Medical Devices · Healthcare
CEO, Board Member
2023-08-10–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $600,920 | $4,823,349 |
| 2024 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $601,398 | $4,136,595 |
| 2023 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $518,077 | $2,692,830 |
| 2022 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | $463,630 | $641,901 |
